Literature DB >> 19732962

Role of dopamine in the physiology of T-cells and dendritic cells.

Rodrigo Pacheco1, Carolina E Prado, Magaly J Barrientos, Sebastián Bernales.   

Abstract

Dendritic cells (DCs) are responsible for priming T-cells and for promoting their differentiation from naïve T-cells into appropriate effector cells. Because of their fundamental roles in controlling immunity, DCs and T-cells require tight regulatory mechanisms. Several studies have shown that dopamine, not only mediate interactions into the nervous system, but can also contribute to the modulation of immunity. Here, we review the emerging role of this neurotransmitter as a regulator of DC and T-cell physiology and, in turn, immune response. Moreover, we discuss how alterations in the dopamine-mediated immune regulatory mechanisms could contribute to the onset of immune-related disorders.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19732962     DOI: 10.1016/j.jneuroim.2009.07.018

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  51 in total

Review 1.  Dopamine Receptors and Neurodegeneration.

Authors:  Claudia Rangel-Barajas; Israel Coronel; Benjamín Florán
Journal:  Aging Dis       Date:  2015-10-01       Impact factor: 6.745

2.  DRD2/AKT1 interaction on D2 c-AMP independent signaling, attentional processing, and response to olanzapine treatment in schizophrenia.

Authors:  Giuseppe Blasi; Francesco Napolitano; Gianluca Ursini; Paolo Taurisano; Raffaella Romano; Grazia Caforio; Leonardo Fazio; Barbara Gelao; Annabella Di Giorgio; Luisa Iacovelli; Lorenzo Sinibaldi; Teresa Popolizio; Alessandro Usiello; Alessandro Bertolino
Journal:  Proc Natl Acad Sci U S A       Date:  2010-12-27       Impact factor: 11.205

3.  Instantaneous depolarization of T cells via dopamine receptors, and inhibition of activated T cells of Psoriasis patients and inflamed human skin, by D1-like receptor agonist: Fenoldopam.

Authors:  Aviad Keren; Amos Gilhar; Yehuda Ullmann; Marina Zlotkin-Frušić; Yoram Soroka; Abraham J Domb; Mia Levite
Journal:  Immunology       Date:  2019-11       Impact factor: 7.397

4.  Phenothiazines induce PP2A-mediated apoptosis in T cell acute lymphoblastic leukemia.

Authors:  Alejandro Gutierrez; Li Pan; Richard W J Groen; Frederic Baleydier; Alex Kentsis; Jason Marineau; Ruta Grebliunaite; Elena Kozakewich; Casie Reed; Francoise Pflumio; Sandrine Poglio; Benjamin Uzan; Paul Clemons; Lynn VerPlank; Frank An; Jason Burbank; Stephanie Norton; Nicola Tolliday; Hanno Steen; Andrew P Weng; Huipin Yuan; James E Bradner; Constantine Mitsiades; A Thomas Look; Jon C Aster
Journal:  J Clin Invest       Date:  2014-01-09       Impact factor: 14.808

Review 5.  Autonomic regulation of T-lymphocytes: Implications in cardiovascular disease.

Authors:  Safwan K Elkhatib; Adam J Case
Journal:  Pharmacol Res       Date:  2019-06-06       Impact factor: 7.658

Review 6.  Where Is Dopamine and how do Immune Cells See it?: Dopamine-Mediated Immune Cell Function in Health and Disease.

Authors:  S M Matt; P J Gaskill
Journal:  J Neuroimmune Pharmacol       Date:  2019-05-11       Impact factor: 4.147

7.  A20 in Multiple Sclerosis and Parkinson's Disease: Clue to a Common Dysregulation of Anti-Inflammatory Pathways?

Authors:  Simona Perga; Serena Martire; Francesca Montarolo; Nicole D Navone; Andrea Calvo; Giuseppe Fuda; Alberto Marchet; Daniela Leotta; Adriano Chiò; Antonio Bertolotto
Journal:  Neurotox Res       Date:  2017-03-23       Impact factor: 3.911

Review 8.  Vaccination strategies for Parkinson disease: induction of a swift attack or raising tolerance?

Authors:  Marina Romero-Ramos; Marianne von Euler Chelpin; Vanesa Sanchez-Guajardo
Journal:  Hum Vaccin Immunother       Date:  2014-03-26       Impact factor: 3.452

9.  Neural Inhibition of Dopaminergic Signaling Enhances Immunity in a Cell-Non-autonomous Manner.

Authors:  Xiou Cao; Alejandro Aballay
Journal:  Curr Biol       Date:  2016-08-11       Impact factor: 10.834

Review 10.  Adrenergic and dopaminergic modulation of immunity in multiple sclerosis: teaching old drugs new tricks?

Authors:  Marco Cosentino; Franca Marino
Journal:  J Neuroimmune Pharmacol       Date:  2012-10-17       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.